Remote Ischemic Postconditioning

Harnessing Endogenous Protection in a Murine Model of Vascular Cognitive Impairment

Mohammad Badruzzaman Khan, MD Nasrul Hoda, Kumar Vaibhav, Shailendra Giri, Lei Wang, Jennifer L Waller, Adviye Ergul, Krishnan Michael Dhandapani, Susan C. Fagan, David C Hess

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

We previously reported that remote limb ischemic conditioning (RLIC; PERconditioning) during acute stroke confers neuroprotection, possibly due to increased cerebral blood flow (CBF). Vascular cognitive impairment (VCI) is a growing threat to public health without any known treatment. The bilateral common carotid artery stenosis (BCAS) mouse model is regarded as the most valid model for VCI. We hypothesized that RLIC (postconditioning; RIPostC) will augment CBF during chronic cerebral hypoperfusion (CCH) and prevent cognitive impairment in the BCAS model. BCAS using customized microcoil was performed in C57/B6 male mice to establish CCH. A week after the BCAS surgery, mice were treated with RIPostC-therapy once daily for 2 weeks. CBF was measured with laser speckle contrast imager at different time points. Cognitive testing was performed at 4-week post-BCAS, and brain tissue was harvested for biochemistry. BCAS led to chronic hypoperfusion resulting into impaired cognitive function as tested by novel object recognition (NOR). Histological examinations revealed that BCAS triggered inflammatory responses and caused frequent vacuolization and cell death. BCAS also increased the generation and accumulation of amyloid beta protein (Aβ), resulting into the loss of white matter (WM) and myelin basic protein (MBP). RIPostC-therapy showed both acute increase as well as sustained improvement in CBF even after the cessation of therapy for a week. RIPostC improved cognitive function, inhibited inflammatory responses, prevented the cell death, reduced the generation and accumulation of Aβ, and protected WM integrity. RIPostC is effective in the BCAS model and could be an attractive low-cost conventional therapy for aged individuals with VCI. The mechanisms by which RIPostC improves CBF and attenuates tissue damage need to be investigated in the future.

Original languageEnglish (US)
Pages (from-to)69-77
Number of pages9
JournalTranslational Stroke Research
Volume6
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Ischemic Postconditioning
Carotid Stenosis
Cerebrovascular Circulation
Blood Vessels
Cognition
Cell Death
Therapeutics
Cognitive Dysfunction
Myelin Basic Protein
Amyloid beta-Peptides
Staphylococcal Protein A
Biochemistry
Lasers
Extremities
Public Health
Stroke

Keywords

  • Arterial stenosis
  • Chronic cerebral hypoperfusion
  • Remote ischemic postconditioning
  • Transient ischemic attacks
  • Vascular cognitive impairment
  • White matter lesion

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

@article{95aa0d2bc449422cb1881b4354048cfd,
title = "Remote Ischemic Postconditioning: Harnessing Endogenous Protection in a Murine Model of Vascular Cognitive Impairment",
abstract = "We previously reported that remote limb ischemic conditioning (RLIC; PERconditioning) during acute stroke confers neuroprotection, possibly due to increased cerebral blood flow (CBF). Vascular cognitive impairment (VCI) is a growing threat to public health without any known treatment. The bilateral common carotid artery stenosis (BCAS) mouse model is regarded as the most valid model for VCI. We hypothesized that RLIC (postconditioning; RIPostC) will augment CBF during chronic cerebral hypoperfusion (CCH) and prevent cognitive impairment in the BCAS model. BCAS using customized microcoil was performed in C57/B6 male mice to establish CCH. A week after the BCAS surgery, mice were treated with RIPostC-therapy once daily for 2 weeks. CBF was measured with laser speckle contrast imager at different time points. Cognitive testing was performed at 4-week post-BCAS, and brain tissue was harvested for biochemistry. BCAS led to chronic hypoperfusion resulting into impaired cognitive function as tested by novel object recognition (NOR). Histological examinations revealed that BCAS triggered inflammatory responses and caused frequent vacuolization and cell death. BCAS also increased the generation and accumulation of amyloid beta protein (Aβ), resulting into the loss of white matter (WM) and myelin basic protein (MBP). RIPostC-therapy showed both acute increase as well as sustained improvement in CBF even after the cessation of therapy for a week. RIPostC improved cognitive function, inhibited inflammatory responses, prevented the cell death, reduced the generation and accumulation of Aβ, and protected WM integrity. RIPostC is effective in the BCAS model and could be an attractive low-cost conventional therapy for aged individuals with VCI. The mechanisms by which RIPostC improves CBF and attenuates tissue damage need to be investigated in the future.",
keywords = "Arterial stenosis, Chronic cerebral hypoperfusion, Remote ischemic postconditioning, Transient ischemic attacks, Vascular cognitive impairment, White matter lesion",
author = "Khan, {Mohammad Badruzzaman} and Hoda, {MD Nasrul} and Kumar Vaibhav and Shailendra Giri and Lei Wang and Waller, {Jennifer L} and Adviye Ergul and Dhandapani, {Krishnan Michael} and Fagan, {Susan C.} and Hess, {David C}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s12975-014-0374-6",
language = "English (US)",
volume = "6",
pages = "69--77",
journal = "Translational Stroke Research",
issn = "1868-4483",
publisher = "Springer US",
number = "1",

}

TY - JOUR

T1 - Remote Ischemic Postconditioning

T2 - Harnessing Endogenous Protection in a Murine Model of Vascular Cognitive Impairment

AU - Khan, Mohammad Badruzzaman

AU - Hoda, MD Nasrul

AU - Vaibhav, Kumar

AU - Giri, Shailendra

AU - Wang, Lei

AU - Waller, Jennifer L

AU - Ergul, Adviye

AU - Dhandapani, Krishnan Michael

AU - Fagan, Susan C.

AU - Hess, David C

PY - 2014/1/1

Y1 - 2014/1/1

N2 - We previously reported that remote limb ischemic conditioning (RLIC; PERconditioning) during acute stroke confers neuroprotection, possibly due to increased cerebral blood flow (CBF). Vascular cognitive impairment (VCI) is a growing threat to public health without any known treatment. The bilateral common carotid artery stenosis (BCAS) mouse model is regarded as the most valid model for VCI. We hypothesized that RLIC (postconditioning; RIPostC) will augment CBF during chronic cerebral hypoperfusion (CCH) and prevent cognitive impairment in the BCAS model. BCAS using customized microcoil was performed in C57/B6 male mice to establish CCH. A week after the BCAS surgery, mice were treated with RIPostC-therapy once daily for 2 weeks. CBF was measured with laser speckle contrast imager at different time points. Cognitive testing was performed at 4-week post-BCAS, and brain tissue was harvested for biochemistry. BCAS led to chronic hypoperfusion resulting into impaired cognitive function as tested by novel object recognition (NOR). Histological examinations revealed that BCAS triggered inflammatory responses and caused frequent vacuolization and cell death. BCAS also increased the generation and accumulation of amyloid beta protein (Aβ), resulting into the loss of white matter (WM) and myelin basic protein (MBP). RIPostC-therapy showed both acute increase as well as sustained improvement in CBF even after the cessation of therapy for a week. RIPostC improved cognitive function, inhibited inflammatory responses, prevented the cell death, reduced the generation and accumulation of Aβ, and protected WM integrity. RIPostC is effective in the BCAS model and could be an attractive low-cost conventional therapy for aged individuals with VCI. The mechanisms by which RIPostC improves CBF and attenuates tissue damage need to be investigated in the future.

AB - We previously reported that remote limb ischemic conditioning (RLIC; PERconditioning) during acute stroke confers neuroprotection, possibly due to increased cerebral blood flow (CBF). Vascular cognitive impairment (VCI) is a growing threat to public health without any known treatment. The bilateral common carotid artery stenosis (BCAS) mouse model is regarded as the most valid model for VCI. We hypothesized that RLIC (postconditioning; RIPostC) will augment CBF during chronic cerebral hypoperfusion (CCH) and prevent cognitive impairment in the BCAS model. BCAS using customized microcoil was performed in C57/B6 male mice to establish CCH. A week after the BCAS surgery, mice were treated with RIPostC-therapy once daily for 2 weeks. CBF was measured with laser speckle contrast imager at different time points. Cognitive testing was performed at 4-week post-BCAS, and brain tissue was harvested for biochemistry. BCAS led to chronic hypoperfusion resulting into impaired cognitive function as tested by novel object recognition (NOR). Histological examinations revealed that BCAS triggered inflammatory responses and caused frequent vacuolization and cell death. BCAS also increased the generation and accumulation of amyloid beta protein (Aβ), resulting into the loss of white matter (WM) and myelin basic protein (MBP). RIPostC-therapy showed both acute increase as well as sustained improvement in CBF even after the cessation of therapy for a week. RIPostC improved cognitive function, inhibited inflammatory responses, prevented the cell death, reduced the generation and accumulation of Aβ, and protected WM integrity. RIPostC is effective in the BCAS model and could be an attractive low-cost conventional therapy for aged individuals with VCI. The mechanisms by which RIPostC improves CBF and attenuates tissue damage need to be investigated in the future.

KW - Arterial stenosis

KW - Chronic cerebral hypoperfusion

KW - Remote ischemic postconditioning

KW - Transient ischemic attacks

KW - Vascular cognitive impairment

KW - White matter lesion

UR - http://www.scopus.com/inward/record.url?scp=84921344340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921344340&partnerID=8YFLogxK

U2 - 10.1007/s12975-014-0374-6

DO - 10.1007/s12975-014-0374-6

M3 - Article

VL - 6

SP - 69

EP - 77

JO - Translational Stroke Research

JF - Translational Stroke Research

SN - 1868-4483

IS - 1

ER -